Genmab — Januar 2026

nohope

Pension.Der skal være kontanter.

Pensionisten

Det kan du have ret i, @nohope. Men, den slags, har man - som regel - nogen tid til af forberede

Pensionisten

Jeg har selv været på pension i en del år - så, ja, jeg skal også hele tiden disponere i.f.t. kommende likviditetsbehov. Der har jeg så valgt, at se på længere sigt, og løbende jmustere lidt.

nohope

Nej, det har man ikke. Får det 1 gang om året ca.1 februar og kender ikke beløbet før nytår. De sidste 3 år er der så kun GEN tilbage, så kursen er meget interssant.

E_L

Barclays analyst James Gordon raised the price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB) to DKK2,500.00 (from DKK2,000.00) while maintaining a Overweight rating. 7-1-26

JKY_VH

tak E L

E_L

Just for interest, JNJ tried another PSMAxCD3 bispecific antibody, after discontinuing the PSMAxCD3 DuoBody a few years ago (JNJ-63898081). Spoiler: it also failed
https://link.springer.com/article/10.1007/s00280-025-04846-w

Sukkeralf

JNJ have taken a another TCE in phase 3 - a KLK2/CD3 made with Zymeworks
platform and has talked about a 1-5 billion peaksale.

E_L

jeez and they are going fast there i see, first-in-human results only last summer , directly to Ph3, skipping Ph2...

tdmtintin

Inside Genmab’s plan to use Anthropic’s AI to speed drug research

Genmab teams will use custom Claude-powered AI agents for data analysis and document generation under human oversight across clinical development.

Stock Titan (www.stocktitan.net)

E_L

when we approached the 2150 area around Christmas i thought, this could seriously pop upon breaking this area... but then the Acasunlimab drop seemed to throw ice on the fire... did not expect this quick return here...

E_L

the october high was 2153

E_L

where is @Legolas23 ? he normally spots these cup /handles...

Raun

Det har været tydeligt de seneste par dage at US har handl
et aktien op og DK handlet aktien ned

Legolas23

I'm here. But do you think it's a cwh we there? I think it's strong if the resistance in 2134 is broken?

E_L

i guess there is a small ugly one starting 1 Dec with cup 2111 - 2138 , but there is a bigger one 17 oct cup 2153 - 2138 ?

E_L

with the bottom of the cup at 1807 you could project a target of 2484 from the 2138 handle break-out

E_L

the EPCORE CLL-1 completion dates moved forward by 1 1/2 year, maybe due to fast recruitment? https://clinicaltrials.gov/study/NCT04623541?tab=history&a=34&b=35&compareMode=sideBySide#version-content-panel really curious if CLL will be pursued with Epco...

E_L

RAINFOL-04 starts recruiting https://clinicaltrials.gov/study/NCT07225270?tab=history&a=5&b=6#version-content-panel

Legolas23

I agree with you. The CWH is full filled. Target 2600.